ABL Diagnostics: Information on voting rights and capital

ABL Diagnostics, a company based in Woippy, has published information regarding its share capital and voting rights. As of May 22, 2026, the share capital consisted of 16,114,656 shares. Theoretical voting rights totaled 30,846,644, while exercisable voting rights amounted to 30,814,120. This data is based on Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation.

Since March 23, 2022, registered shares held for at least two years have been granted double voting rights. ABL Diagnostics, specializing in molecular biology testing, is listed on Euronext Paris. It offers advanced detection solutions in various fields, including HIV and SARS-CoV-2.